We partner with leading pharmaceutical companies who are looking to accelerate innovation and unlock clinical value by leveraging the power of inhaled therapeutics.
We partner with leading pharmaceutical companies who are looking to accelerate innovation and unlock clinical value by leveraging the power of inhaled therapeutics.
Co-development partnerships –
Partner therapies
Strategic partnerships to develop innovative therapies by applying Transpire Bio’s inhalation technology platforms to a pharmaceutical partner’s existing novel or in-market therapeutics.
Co-Development partnerships –
Transpire Bio therapies
Strategic partnerships and licensing agreements to bring Transpire Bio’s early-stage and mid-stage therapeutic assets to market by leveraging a pharmaceutical partner’s late-stage clinical, regulatory, and commercialization capabilities.
Commercialization partnerships –
Complex generics
Licensing agreements for the commercialization of one of Transpire Bio’s early-entry, difficult-to-replicate asthma/COPD generic inhaled therapies.
© 2025 Transpire Bio Inc. All Rights Reserved.